Dachaigh › Aillse a' bhroilleach › New York

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an New York

Tha 176 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, New York
Research Site, New York

A’ fastadhÌre 1/2

Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05417594

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
agus 1 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06982521

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Kings County Hopsital Center, Brooklyn
Queens Cancer Center of Queens Hospital, Jamaica
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
agus 1 a bharrachd

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04751435

A Study of Mental Health Care in People With Cancer

Memorial Sloan Kettering Cancer Center, New York

A’ fastadh

Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06037954

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06784193

A Study of PHST001 in Advanced Solid Tumors

START Center for Cancer Research - Long Island New York, Lake Success
Mount Sinai, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06840886

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
agus 1 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05534438

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Roswell Park Cancer Institute, Buffalo

A’ fastadhFàilte do shaor-thoilich fhallain

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Dàmh 2026 · NCT03897270

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

A’ fastadhÌre 1/2

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Queens Cancer Center of Queens Hospital, Jamaica
Optum Health, Lake Success
Mount Sinai School of Medicine, New York

A’ fastadhÌre 3

Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, New York

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07205822

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Hematology Oncology Associates of Central New York, Camillus
Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07102381

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07701941

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Roswell Park Comprehensive Cancer Center, Buffalo

A’ fastadhÌre 2

Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT04305834

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Rochester Medical Center, Rochester

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Memorial Sloan-Kettering Cancer Center, New York
New York Cancer & Blood Specialists, Shirley

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06324357

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
agus 1 a bharrachd

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07218250

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

New York Proton Center, New York

A’ fastadhÌre 2

Aoisean 50 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT01766297

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05877599

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

New York Proton Center, New York

A’ fastadhÌre 3

Aoisean 19 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05856773

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Queens Hospital Cancer Center ( Site 0011), Jamaica
Optum Medical Care, PC ( Site 0009), Westbury

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NYU Langone Health - Brooklyn ( Site 0089), Brooklyn
NYU Langone Hospital - Long Island ( Site 0090), Mineola
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
agus 2 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New York
Research Site, Stony Brook

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07007559

A Study of Language Interpretation Solutions for People With Breast Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
agus 2 a bharrachd

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
agus 1 a bharrachd

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT05412225

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

New York Cancer and Blood Specialists, Babylon
NYU Langone Health, New York
University of Rochester (URMC), Rochester
agus 1 a bharrachd

A’ fastadh

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, New York
Clinical Trial Site, New York

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07085767

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07114601

Intra-Operative Radiation Registry

Montefiore Medical Center - Moses Campus, The Bronx

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Sult 2026 · NCT04994067

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NYOH Albany Cancer Center, Albany
New York University (NYU) Brooklyn, Brooklyn
Memorial Sloan Kettering Cancer Center, New York
agus 1 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Memorial Sloan Kettering Cancer Center, New York
Wilmot Cancer Institute, Rochester
New York Cancer and Blood Specialists, Shirley

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Sult 2026 · NCT07287098

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Weill Cornell Medicine, New York

A’ fastadhFàilte do shaor-thoilich fhallain

Aoisean 30 gu 74 · Banairean · Air ùrachadh 21 Sult 2026 · NCT02620852

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
agus 1 a bharrachd

A’ fastadhÌre 2

Aoisean 45 agus nas sine · Banairean · Air ùrachadh 21 Sult 2026 · NCT04084730

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Memorial Sloan Kettering Cancer Center Westchester, Harrison
Beth Israel Comprehensive Cancer Center, New York
Mount Sinai Medical Center, New York
agus 5 a bharrachd

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06827236

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.